| Christine Kasser, MD | |
|
320 S Walnut Bend Rd, Suite 5, Cordova, TN 38018-7283 | |
| (901) 751-7080 | |
| (901) 751-7094 |
| Full Name | Christine Kasser |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine - Addiction Medicine |
| Location | 320 S Walnut Bend Rd, Cordova, Tennessee |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770607665 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 19142 (Tennessee) | Primary |
| 207RA0401X | Internal Medicine - Addiction Medicine | 19142 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christine Kasser, MD 320 S Walnut Bend Rd, Suite 5, Cordova, TN 38018-7283 Ph: () - | Christine Kasser, MD 320 S Walnut Bend Rd, Suite 5, Cordova, TN 38018-7283 Ph: (901) 751-7080 |
News Archive
A UCSF institute aimed at accelerating the pace of translating science into real-life solutions for patients has received $112 million from the National Institutes of Health to expand its work over the next five years.
Army doctors in the First World War were helpless to stop soldiers who lost limbs from suffering in pain, according to researchers.
Brenda Milner, Ph.D., a pioneer in the field of cognitive neuroscience whose discoveries revolutionized the understanding of memory, was awarded the 2011 Pearl Meister Greengard Prize from The Rockefeller University yesterday.
Inviragen and PharmaJet announced the award of a five year, $15.5 million dollar contract from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to advance the development of a needle-free, easy to administer dengue vaccine. The award will fund preclinical studies, regulatory filings, manufacturing and clinical testing of Inviragen's tetravalent dengue vaccine, DENVax delivered with PharmaJet's convenient needle-free injection device.
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
› Verified 9 days ago
Dr. Gary David Strasberg, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2551 Ashburton Pl N, Cordova, TN 38016 Phone: 901-275-4922 | |
Gregory K Jenkins, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8138 Country Village Dr, Cordova, TN 38016 Phone: 901-260-3100 Fax: 901-755-1113 | |
Dr. Catherine Mulroy Munn, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8138 Country Village Dr, Cordova, TN 38016 Phone: 901-260-3100 Fax: 901-755-1113 | |
Dr. Sandra W Cohen, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 57 Germantown Ct, Suite 100, Cordova, TN 38018 Phone: 901-758-7888 Fax: 901-266-6445 | |
Charles R Arkin, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 540 Trinity Creek Cv, Cordova, TN 38018 Phone: 901-309-5000 Fax: 901-309-5008 | |
Dr. John M Bills Jr., MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1660 Bonnie Ln Ste 105, Cordova, TN 38016 Phone: 901-888-1000 | |
Dr. Frank John Adcock Iii, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 8596 Rockcreek Pkwy, Cordova, TN 38016 Phone: 901-372-4350 Fax: 901-372-4350 |